Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India · Delayed Price · Currency is INR 2,225.00
+20.20 (0.92%)
Jul 17, 2025, 3:29 PM IST
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 622.20 billion as of July 17, 2025. Its market cap has increased by 79.19% in one year.
Market Cap
622.20B
Enterprise Value
629.87B
Revenue
134.35B
Ranking
n/a
PE Ratio
59.43
Stock Price
2,225.00
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 622.20B, an increase of 54,036.83%. That is a compound annual growth rate of 29.81%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,144.85B |
| Divi's Laboratories | 1,802.53B |
| Cipla | 1,204.28B |
| Mankind Pharma | 1,094.14B |
| Apollo Hospitals Enterprise | 1,038.13B |
| Zydus Lifesciences | 973.68B |
| Aurobindo Pharma | 669.08B |
| Fortis Healthcare | 603.40B |